Currently, there are 248.53M common shares owned by the public and among those 246.49M shares have been available to trade.
The company’s stock has a 5-day price change of -5.29% and 15.53% over the past three months. MAC shares are trading 31.11% year to date (YTD), with the 12-month market performance up to 31.28% higher. It has a 12-month low price of $12.99 and touched a high of $22.27 over the same period. MAC has an average intraday trading volume of 2.07 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -3.95%, 2.10%, and 20.49% respectively.
Institutional ownership of Macerich Co (NYSE: MAC) shares accounts for 85.66% of the company’s 248.53M shares outstanding.
It has a market capitalization of $5.23B and a beta (3y monthly) value of 2.56. The earnings-per-share (ttm) stands at -$0.90. The company has a debt-to-equity ratio at 1.74. Price movements for the stock have been influenced by the stock’s volatility, which stands at 4.09% over the week and 3.05% over the month.
Analysts forecast that Macerich Co (MAC) will achieve an EPS of 0.03 for the current quarter, -0.17 for the next quarter and -0.38 for current fiscal year. The lowest estimate earnings-per-share for the quarter is 0.03 while analysts give the company a high EPS estimate of 0.03. Comparatively, EPS for the current quarter was 0.27 a year ago. Earnings per share for the fiscal year are expected to increase by 108.92%, and -238.77% over the next financial year.
Looking at the support for the MAC, a number of firms have released research notes about the stock. Scotiabank stated their Sector Perform rating for the stock in a research note on December 17, 2024, with the firm’s price target at $22. Deutsche Bank coverage for the Macerich Co (MAC) stock in a research note released on December 17, 2024 offered a Hold rating with a price target of $22. Mizuho was of a view on December 04, 2024 that the stock is Neutral, while Scotiabank gave the stock Sector Underperform rating on May 17, 2024, issuing a price target of $16- $14. Piper Sandler on their part issued Underweight rating on May 01, 2024.
